Enhancing the Informativeness and Replicability of Imaging Genomics Studies

Cameron S Carter, Carrie E. Bearden, Edward T. Bullmore, Daniel H. Geschwind, David C. Glahn, Raquel E. Gur, Andreas Meyer-Lindenberg, Daniel R. Weinberger

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Imaging genomics is a new field of investigation that seeks to gain insights into the impact of human genetic variation on the structure, chemistry, and function of neural systems in health and disease. Because publications in this field have increased over the past decade, increasing concerns have been raised about false-positive results entering the literature. Here, we provide an overview of the field of imaging genomic and genetic approaches and discuss factors related to research design and analysis that can enhance the informativeness and replicability of these studies. We conclude that imaging genetic studies can provide important insights into the role of human genetic variation on neural systems and circuits, both in the context of normal quantitative variation and in relation to neuropsychiatric disease. We also argue that demonstrating genetic association to imaging-derived traits is subject to the same constraints as any other genetic study, including stringent type I error control. Adequately powered studies are necessary; however, there are currently limited data available to allow precise estimates of effect sizes for candidate gene studies. Independent replication is necessary before a result can be considered definitive, and for studies with small sample sizes it is necessary before publication. Increased transparency of methods and enhanced data sharing will further enhance replicability.

Original languageEnglish (US)
JournalBiological Psychiatry
DOIs
StateAccepted/In press - Oct 11 2014

Fingerprint

Medical Genetics
Genomics
Publications
Information Dissemination
Sample Size
Research Design
Health
Genes

Keywords

  • Clinical confounds
  • Imaging genomics
  • Multiple comparisons
  • Replication
  • Sample size
  • Statistical power

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Carter, C. S., Bearden, C. E., Bullmore, E. T., Geschwind, D. H., Glahn, D. C., Gur, R. E., ... Weinberger, D. R. (Accepted/In press). Enhancing the Informativeness and Replicability of Imaging Genomics Studies. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2016.08.019

Enhancing the Informativeness and Replicability of Imaging Genomics Studies. / Carter, Cameron S; Bearden, Carrie E.; Bullmore, Edward T.; Geschwind, Daniel H.; Glahn, David C.; Gur, Raquel E.; Meyer-Lindenberg, Andreas; Weinberger, Daniel R.

In: Biological Psychiatry, 11.10.2014.

Research output: Contribution to journalArticle

Carter, CS, Bearden, CE, Bullmore, ET, Geschwind, DH, Glahn, DC, Gur, RE, Meyer-Lindenberg, A & Weinberger, DR 2014, 'Enhancing the Informativeness and Replicability of Imaging Genomics Studies', Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2016.08.019
Carter, Cameron S ; Bearden, Carrie E. ; Bullmore, Edward T. ; Geschwind, Daniel H. ; Glahn, David C. ; Gur, Raquel E. ; Meyer-Lindenberg, Andreas ; Weinberger, Daniel R. / Enhancing the Informativeness and Replicability of Imaging Genomics Studies. In: Biological Psychiatry. 2014.
@article{3db390cc34bd457789497a40bb267bc0,
title = "Enhancing the Informativeness and Replicability of Imaging Genomics Studies",
abstract = "Imaging genomics is a new field of investigation that seeks to gain insights into the impact of human genetic variation on the structure, chemistry, and function of neural systems in health and disease. Because publications in this field have increased over the past decade, increasing concerns have been raised about false-positive results entering the literature. Here, we provide an overview of the field of imaging genomic and genetic approaches and discuss factors related to research design and analysis that can enhance the informativeness and replicability of these studies. We conclude that imaging genetic studies can provide important insights into the role of human genetic variation on neural systems and circuits, both in the context of normal quantitative variation and in relation to neuropsychiatric disease. We also argue that demonstrating genetic association to imaging-derived traits is subject to the same constraints as any other genetic study, including stringent type I error control. Adequately powered studies are necessary; however, there are currently limited data available to allow precise estimates of effect sizes for candidate gene studies. Independent replication is necessary before a result can be considered definitive, and for studies with small sample sizes it is necessary before publication. Increased transparency of methods and enhanced data sharing will further enhance replicability.",
keywords = "Clinical confounds, Imaging genomics, Multiple comparisons, Replication, Sample size, Statistical power",
author = "Carter, {Cameron S} and Bearden, {Carrie E.} and Bullmore, {Edward T.} and Geschwind, {Daniel H.} and Glahn, {David C.} and Gur, {Raquel E.} and Andreas Meyer-Lindenberg and Weinberger, {Daniel R.}",
year = "2014",
month = "10",
day = "11",
doi = "10.1016/j.biopsych.2016.08.019",
language = "English (US)",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Enhancing the Informativeness and Replicability of Imaging Genomics Studies

AU - Carter, Cameron S

AU - Bearden, Carrie E.

AU - Bullmore, Edward T.

AU - Geschwind, Daniel H.

AU - Glahn, David C.

AU - Gur, Raquel E.

AU - Meyer-Lindenberg, Andreas

AU - Weinberger, Daniel R.

PY - 2014/10/11

Y1 - 2014/10/11

N2 - Imaging genomics is a new field of investigation that seeks to gain insights into the impact of human genetic variation on the structure, chemistry, and function of neural systems in health and disease. Because publications in this field have increased over the past decade, increasing concerns have been raised about false-positive results entering the literature. Here, we provide an overview of the field of imaging genomic and genetic approaches and discuss factors related to research design and analysis that can enhance the informativeness and replicability of these studies. We conclude that imaging genetic studies can provide important insights into the role of human genetic variation on neural systems and circuits, both in the context of normal quantitative variation and in relation to neuropsychiatric disease. We also argue that demonstrating genetic association to imaging-derived traits is subject to the same constraints as any other genetic study, including stringent type I error control. Adequately powered studies are necessary; however, there are currently limited data available to allow precise estimates of effect sizes for candidate gene studies. Independent replication is necessary before a result can be considered definitive, and for studies with small sample sizes it is necessary before publication. Increased transparency of methods and enhanced data sharing will further enhance replicability.

AB - Imaging genomics is a new field of investigation that seeks to gain insights into the impact of human genetic variation on the structure, chemistry, and function of neural systems in health and disease. Because publications in this field have increased over the past decade, increasing concerns have been raised about false-positive results entering the literature. Here, we provide an overview of the field of imaging genomic and genetic approaches and discuss factors related to research design and analysis that can enhance the informativeness and replicability of these studies. We conclude that imaging genetic studies can provide important insights into the role of human genetic variation on neural systems and circuits, both in the context of normal quantitative variation and in relation to neuropsychiatric disease. We also argue that demonstrating genetic association to imaging-derived traits is subject to the same constraints as any other genetic study, including stringent type I error control. Adequately powered studies are necessary; however, there are currently limited data available to allow precise estimates of effect sizes for candidate gene studies. Independent replication is necessary before a result can be considered definitive, and for studies with small sample sizes it is necessary before publication. Increased transparency of methods and enhanced data sharing will further enhance replicability.

KW - Clinical confounds

KW - Imaging genomics

KW - Multiple comparisons

KW - Replication

KW - Sample size

KW - Statistical power

UR - http://www.scopus.com/inward/record.url?scp=85006021660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006021660&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2016.08.019

DO - 10.1016/j.biopsych.2016.08.019

M3 - Article

C2 - 27793332

AN - SCOPUS:85006021660

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

ER -